ATE390934T1 - Aspirin enthaltende transdermale pharmazeutische zusammensetzung zur behandlung von verkalkung - Google Patents

Aspirin enthaltende transdermale pharmazeutische zusammensetzung zur behandlung von verkalkung

Info

Publication number: ATE390934T1
Authority: AT; Austria
Prior art keywords: calcification; treatment; pharmaceutical composition; composition containing; transdermal pharmaceutical
Prior art date: 2001-11-16

Application number

AT02777584T

Other languages

English (en)

Inventor

Zoltan Dardai

Original Assignee

Zoltan Dardai

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-16

Filing date

2002-10-31

Publication date

2008-04-15

2002-10-31 Application filed by Zoltan Dardai filed Critical Zoltan Dardai

2008-04-15 Application granted granted Critical

2008-04-15 Publication of ATE390934T1 publication Critical patent/ATE390934T1/de

Links

BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 title abstract 3
229960001138 acetylsalicylic acid Drugs 0.000 title abstract 3
230000002308 calcification Effects 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 abstract 2
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 abstract 1
ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 abstract 1
208000004434 Calcinosis Diseases 0.000 abstract 1
229910052783 alkali metal Inorganic materials 0.000 abstract 1
229910000288 alkali metal carbonate Inorganic materials 0.000 abstract 1
150000008041 alkali metal carbonates Chemical class 0.000 abstract 1
150000001340 alkali metals Chemical class 0.000 abstract 1
239000001099 ammonium carbonate Substances 0.000 abstract 1
235000012501 ammonium carbonate Nutrition 0.000 abstract 1
239000001569 carbon dioxide Substances 0.000 abstract 1
229910002092 carbon dioxide Inorganic materials 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Inorganic Chemistry (AREA)
Dermatology (AREA)
Physical Education & Sports Medicine (AREA)
Endocrinology (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

AT02777584T 2001-11-16 2002-10-31 Aspirin enthaltende transdermale pharmazeutische zusammensetzung zur behandlung von verkalkung ATE390934T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
HU0104968A HU227496B1 (en)	2001-11-16	2001-11-16	Transdermal pharmaceutical composition containing aspirine for the treatment of sclerosis

Publications (1)

Publication Number	Publication Date
ATE390934T1 true ATE390934T1 (de)	2008-04-15

Family

ID=50701118

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02777584T ATE390934T1 (de)	2001-11-16	2002-10-31	Aspirin enthaltende transdermale pharmazeutische zusammensetzung zur behandlung von verkalkung

Country Status (11)

Country	Link
US (1)	US20050004084A1 (de)
EP (1)	EP1446160B1 (de)
CN (1)	CN100342913C (de)
AT (1)	ATE390934T1 (de)
CA (1)	CA2465334A1 (de)
DE (1)	DE60225939D1 (de)
EA (1)	EA200400650A1 (de)
HU (1)	HU227496B1 (de)
UA (1)	UA82472C2 (de)
WO (1)	WO2003041743A1 (de)
ZA (1)	ZA200403220B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050074503A1 (en) *	2003-10-05	2005-04-07	Brilman Yakov Yevseyevich	Bilious balsam
WO2011076401A1 (de)	2009-12-23	2011-06-30	Holger Schankin	Acetylsalicylsäure-haltige, im wesentlichen wasserfreie pharmazeutische zusammensetzungen
ES2525766B1 (es) *	2013-06-24	2015-10-13	Linguaversal S.L.	Sistema y método para mejorar la percepción de los sonidos de un idioma extranjero
EP4112043A1 (de) *	2021-06-30	2023-01-04	GSK Consumer Healthcare SARL	Nanokomplexzusammensetzung mit diclofenac

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL44774A (en) *	1974-05-06	1977-07-31	Baron E	Pharmaceutical composition containing acetyl salicyclic acid
US4275059A (en) *	1977-03-28	1981-06-23	The Procter & Gamble Company	Salicylate anti-inflammatory composition
US5037648A (en) *	1989-11-20	1991-08-06	Joiner Evelyn S	Skin conditioning preparation having a pH above 7, method and method of making
US5140068A (en) *	1990-04-27	1992-08-18	The B. F. Goodrich Company	Epoxy resin systems modified with low viscosity statistical monofunctional reactive polymers
US5176918A (en) *	1990-12-20	1993-01-05	Jones Jeffry L	Topical medicament
US5612382A (en) *	1994-07-15	1997-03-18	Frances B. Fike	Composition for percutaneous absorption of pharmaceutically active ingredients
JPH1112177A (ja) *	1997-06-25	1999-01-19	Teikoku Seiyaku Co Ltd	安定なアスピリン含有外用製剤
US6623751B2 (en) *	1998-07-30	2003-09-23	L'oreal S.A.	Cosmetic, pharmaceutical, or dermatological patch
HU9902296D0 (en) *	1999-07-07	1999-10-28	Dardai	Pharmaceutical composition for treating caltification
US6645520B2 (en) *	1999-12-16	2003-11-11	Dermatrends, Inc.	Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers

2001
- 2001-11-16 HU HU0104968A patent/HU227496B1/hu not_active IP Right Cessation
2002
- 2002-10-31 CA CA002465334A patent/CA2465334A1/en not_active Abandoned
- 2002-10-31 AT AT02777584T patent/ATE390934T1/de not_active IP Right Cessation
- 2002-10-31 EP EP02777584A patent/EP1446160B1/de not_active Expired - Lifetime
- 2002-10-31 EA EA200400650A patent/EA200400650A1/ru unknown
- 2002-10-31 CN CNB028227085A patent/CN100342913C/zh not_active Expired - Fee Related
- 2002-10-31 DE DE60225939T patent/DE60225939D1/de not_active Expired - Lifetime
- 2002-10-31 UA UA20040604708A patent/UA82472C2/uk unknown
- 2002-10-31 WO PCT/HU2002/000112 patent/WO2003041743A1/en not_active Ceased
- 2002-10-31 US US10/495,778 patent/US20050004084A1/en not_active Abandoned
2004
- 2004-04-29 ZA ZA200403220A patent/ZA200403220B/en unknown

Also Published As

Publication number	Publication date
CN100342913C (zh)	2007-10-17
ZA200403220B (en)	2004-07-28
US20050004084A1 (en)	2005-01-06
HUP0104968A2 (hu)	2004-05-28
CN1610558A (zh)	2005-04-27
EP1446160A1 (de)	2004-08-18
UA82472C2 (uk)	2008-04-25
CA2465334A1 (en)	2003-05-22
EA200400650A1 (ru)	2004-10-28
HUP0104968D0 (en)	2002-01-28
HU227496B1 (en)	2011-07-28
EP1446160B1 (de)	2008-04-02
HK1071056A1 (en)	2005-07-08
DE60225939D1 (de)	2008-05-15
WO2003041743A1 (en)	2003-05-22

Similar Documents

Publication	Publication Date	Title
ATE289332T1 (de)	2005-03-15	Silikongel enthaltend salizylsäure
ATE257386T1 (de)	2004-01-15	Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
EA200501805A1 (ru)	2006-06-30	Фармацевтическая композиция, содержащая ингибитор фермента дипептидилпептидазы
ATE361084T1 (de)	2007-05-15	Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
DE60143360D1 (de)	2010-12-09	Zusammensetzung zur transdermalen und/oder transmukosalen Verabreichung von Wirkstoffen, die ausreichende therapeutische Spiegel garantiert
PT705100E (pt)	2003-12-31	Guanidinas substituidas terapeuticas
BRPI0414876A (pt)	2006-11-21	compostos e composições farmcêuticas para prevenção de overdose ou abuso e respectivos usos
BRPI0007487B8 (pt)	2021-05-25	difenil-uréias substituídas com w-carbóxi-arilas como inibidores de raf cinase
DE60111539D1 (de)	2005-07-21	Pharmazeutische zusammensetzung enthaltend ein 5-aminolaevulinsäure-ester als photochemotherapeutikum und ein mucoadhäsivum
DE60236541D1 (de)	2010-07-08	Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1
BR9906920A (pt)	2000-10-10	"tts contendo um antioxidante"
ATE203019T1 (de)	2001-07-15	Neue (r)-5-carbamoyl-8-fluor-3-n,n- disubstituierte-amino-3,4-dihydro-2h-1- benzopyrane
BR0110659A (pt)	2003-02-11	Composição farmacêutica, kit, uso de um fator viia em combinação com um fator, xiii, e, métodos para intensificação da formação de coágulo de fibrina em um indivìduo e para tratar de episódios de hemorragia em um indivìduo
DE60126980D1 (de)	2007-04-12	Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
DK1363608T3 (da)	2006-02-13	Formuleringer omfattende ibuprofen og diphenhydramin og deres anvendelse til behandling af sovnforstyrrelser
ATE413179T1 (de)	2008-11-15	Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
BR0318278A (pt)	2006-05-23	compostos de éter aminocicloexìlico e usos dos mesmo
DE602004017871D1 (de)	2009-01-02	Zubereitungen zur behandlung von arthritischen erscheinungen
BR9911917A (pt)	2001-03-27	Composições compreendendo análogos de gaba e cafeìna
BRPI0415781A (pt)	2006-12-26	método para o tratamento de diabetes em um paciente e kit farmacêutico
ATE445409T1 (de)	2009-10-15	Zusammensetzungen mit matrixproteinen zur regeneration von dentin
EP1037918A4 (de)	2004-11-03	Verfahren und zusammensetzungen zur steigerung der effizienz von impfstoffen unter verwendung von chemokinen
ATE390934T1 (de)	2008-04-15	Aspirin enthaltende transdermale pharmazeutische zusammensetzung zur behandlung von verkalkung
DE69429856D1 (de)	2002-03-21	Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit
DE60214207D1 (de)	2006-10-05	Nagellack enthaltend tazaroten und verwendung dessen zur behandlung und/oder zur prävention von psoriasis

Legal Events

Date	Code	Title	Description
2008-10-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties